Quick answers
- What is Ivermectin used for?
- The FDA-approved label (Stromectol, Merck Sharp & Dohme LLC, September 20, 2024) says: “STROMECTOL is indicated for the treatment of the following infections: Strongyloidiasis of the intestinal tract. STROMECTOL is indicated for the treatment of intestinal (i.e., nondisseminated) strongyloidiasis due to the nematode parasite Strongyloides stercoralis. …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Ivermectin have a boxed warning?
- No. None of the 20 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Ivermectin?
- The FDA drug shortage list shows “To be discontinued” for a product of this medicine (updated September 29, 2026). Ask your pharmacist about alternatives.
- Has Ivermectin been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Ivermectin?
- 16 companies list prescription products of Ivermectin in the FDA NDC Directory, including Bryant Ranch Prepack, Advagen Pharma Ltd and Zydus Lifesciences Limited.
What Ivermectin is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
STROMECTOL is indicated for the treatment of the following infections: Strongyloidiasis of the intestinal tract. STROMECTOL is indicated for the treatment of intestinal (i.e., nondisseminated) strongyloidiasis due to the nematode parasite Strongyloides stercoralis. …
— FDA label: Stromectol, Merck Sharp & Dohme LLC, effective September 20, 2024. Read the full label on DailyMed →
The FDA has 20 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 20 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Tablet · Cream |
|---|---|
| Route | Oral · Topical |
| Prescription products | 21 in the FDA NDC Directory |
| Brand names | Stromectol, Soolantra |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| ivermectin 1% cream | Generic | $2.61 per gram |
| ivermectin 1% cream | Brand: Soolantra | $15.50 per gram |
| ivermectin 3 mg tablet | Generic | $2.03 per tablet |
| ivermectin 3 mg tablet | Brand: Stromectol | $4.46 per tablet |
| ivermectin 6 mg tablet | Generic | $9.86 per tablet |
NADAC list of November 4, 2026; these prices took effect between November 19, 2025 and October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Bryant Ranch Prepack3 products
- Advagen Pharma Ltd2 products
- Zydus Lifesciences Limited2 products
- Viona Pharmaceuticals Inc2 products
- Padagis Israel Pharmaceuticals Ltd1 product
- NuCare Pharmaceuticals, Inc.1 product
- Dr. Reddy's Laboratories Inc.1 product
- Mayne Pharma Inc.1 product
- Merck Sharp & Dohme LLC1 product
- A-S Medication Solutions1 product
- Ajanta Pharma USA Inc.1 product
- Epic Pharma, LLC1 product
- Asclemed USA, Inc.1 product
- Actavis Pharma, Inc.1 product
- Edenbridge Pharmaceuticals LLC.1 product
- Galderma Laboratories, L.P.1 product
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA050742 STROMECTOL | Merck Sharp Dohme | November 22, 1996 | 25, latest March 14, 2022 2022: Labeling · 2015: Manufacturing (CMC) · 2015: Manufacturing (CMC) |
| NDA206255 SOOLANTRA | Galderma Labs LP | December 19, 2014 | 3, latest October 14, 2022 2022: Labeling · 2022: Labeling · 2018: Labeling |
Generic approvals (9)
- ANDA204154Edenbridge Pharms · October 24, 2014
- ANDA210019Teva Pharms USA · September 13, 2019
- ANDA210225Padagis Israel · April 13, 2020
- ANDA215210Zydus Lifesciences · August 2, 2022
- ANDA218324Pharmazone · October 16, 2024
- ANDA215922Rubicon Research · January 22, 2025
- ANDA218805Epic Pharma LLC · September 9, 2025
- ANDA216863Zydus Lifesciences · February 26, 2026
- ANDA218509Ajanta Pharma Ltd · April 7, 2026
Shortage status
To be discontinued · updated September 29, 2026 · first posted September 29, 2026
| Product | STROMECTOL, Tablet, 3 mg (NDC 0006-0032-01) |
|---|---|
| Company | Merck Sharp & Dohme LLC |
Ask your pharmacist whether your product is affected and what the options are.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Stromectol, Merck Sharp & Dohme LLC, effective September 20, 2024; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →